The New Classification of NET

Journal Title: OncoReview - Year 2011, Vol 1, Issue 1

Abstract

There are three imporant directions in the field of GEP NET. The first one is the NET Registry which collects the data from different clinical centers, that can be compared, providing the konwledge of these tumors. The second one is the diagnosis assessment where the patomorphological report is based on generally accepted nomenclatures and classifications. The quality of the report is fundamental for the therapeutic decision.The third problem is the prognostic and predictive markers for stratification of patients for therapy: observation, biotherapy or chemotherapy. The large epidemiologcal data from US published by Modlin, Maggard and Yao present the tendency for the increase of the incidence of NET during 5 and 3 decades from 1.09 to 5.25 in 100 000 population per year. They also showed the increase in the rectum and stomach NET and decrease in appendix NET. Epidemiological European data based on a smaller number of cases as compared to US data. Larger data are from Germany, Spain, Norway and Austria. The systems of NET nomenclature are based on the morphology, differentiation and grading of NET. Fundamental in all systems is a sharp division between well differentiated and poorly differentiated tumors. The grade reflects the biologic behavior and agressiveness of the tumor. All classifications and guidelines for diagnosis and therapy regardless of the sources are based on 3 fundamental features, the type of NET according to WHO classification, grading and staging based on ENETS and AJCC/UICC TNM system.

Authors and Affiliations

Anna Nasierowska-Guttmejer

Keywords

Related Articles

Steroid-induced diabetes in oncology

Patients with neoplasms belong to the group of higher risk for developing steroid-induced diabetes. The rules of diagnosis of this form of diabetes do not differ from others of its type, but the course and treatment diff...

Rola i miejsce jakości życia w nowoczesnym leczeniu chorych na raka płuca

Jakość życia to osobisty sposób postrzegania przez jednostkę pozycji zajmowanej w życiu w kontekście kultury i systemu wartości oraz w odniesieniu do stawianych sobie celów, oczekiwań i obaw. Chorzy zmieniają postrzegani...

Nuclear medicine diagnostic tools for early detection of myocardial damage in treated breast cancer patients

The most severe side effect in treated patients with breast cancer is treatment-induced cardiotoxicity, leading to chronic heart failure or CAD, and worsening the patient’s quality of life. The early detection and medica...

Late relapse of chronic myeloid leukemia after allogeneic stem cell tranplan

Chronic myeloid leukemia now is a disease which in the most cases is well manageable with tyrosine kinase inhibitors treatment. Still however the only potentially curable therapeutic approach is for chronic myeloid leuke...

Original vs generic drugs in treatment of chronic myeloid leukaemia

The beginning of the twenty-first century saw a breakthrough in haematology, oncology and general medicine driven by the introduction of imatinib (Glivec) to the treatment of chronic myeloid leukaemia. For the first time...

Download PDF file
  • EP ID EP53091
  • DOI -
  • Views 263
  • Downloads 0

How To Cite

Anna Nasierowska-Guttmejer (2011). The New Classification of NET. OncoReview, 1(1), -. https://europub.co.uk/articles/-A-53091